Kentucky Retirement Systems Insurance Trust Fund bought a new position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,597 shares of the life sciences company’s stock, valued at approximately $1,302,000. […]
Veritas Asset Management LLP reduced its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 0.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,550,097 shares of the life sciences company’s stock after selling 7,829 shares during the period. Illumina comprises 2.7% of Veritas Asset Management LLP’s […]
Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Canaccord Genuity Group from $300.00 to $285.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the life sciences company’s stock. Canaccord Genuity Group’s price objective indicates a potential upside of 65.85% from the stock’s […]
Vestor Capital LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 1,635.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 19,258 shares of the life sciences company’s stock after buying an additional 18,148 shares during the quarter. Vestor Capital […]
Illumina (NASDAQ:ILMN – Get Free Report) had its price objective decreased by equities research analysts at HSBC from $270.00 to $235.00 in a report issued on Monday, FlyOnTheWall reports. HSBC’s price target would indicate a potential upside of 30.21% from the stock’s previous close. Several other research analysts also recently issued reports on the stock. […]